MMDC is a radical way to develop and deploy connected healthtech - fast.
MMDC delivers accelerated development of regulated digital health products and globally scalable, compliant product and data management. And, MMDC provides established healthcare connections to get new products integrated rapidly, for accelerated deployment and cashflows.
L2S2's MMDC compliant services are, moreover, trusted by NHS Digital to hold and process massive datasets of sensitive healthcare and patient data using AI algorithms and other analytics.
Discover the power of MMDC
MMDC is a comprehensive solution
Interoperability
L2S2 commits to working to healthcare IT standards and to have an open API policy. In short, if you need to connect to another IT system, we will put in place the governance, technology and skills to make it happen.
Xenplate Rapid Application Development (RAD)
L2S2's MMDC platform has a friendly self-auditing drag-and-drop editor for rapid, agile and compliant development of new apps, applications and research protocols. You don't need software skills to use it. Each designs work on iOS, Android, UWP and web browser automatically.
Analytics, AI & ML, and API
Compliance
The MMDC standard provides healthcare and research compliance - out of the box. It meets strict NHS IT guidelines & GxP for life sciences research. MMDC complies to EU MDR and GDPR, OWASP, FDA 21 CFR Part 11 and HIPAA. L2S2 is accredited to ISO 13485:2016, ISO/IEC 27001:2013, NHS DS&P Toolkit & Cyber Essentials.
Support
L2S2 can take care of all aspects of product deployment and provides full Tier 2 and Tier 3 support. Proactive end-user support is also available. We maintain our quality accreditations for you to rely on and we maintain all systems so that each time a new iOS or Android release is issued, you don't even miss a beat.
Clinical, technical, governance and regulatory expertise
MMDC app wins across the board!
Assessing pre-operative risk for patients is incredibly complex. Risks of mortality and complications change radically with differences in physiological variables and the severity of planned operations. Compass reduces avoidable harm in hospitals by enabling clinicians to give patients targeted, precision care. It provides bespoke risk assessments for complications and mortality in less than a minute. for many different conditions and procedures.
Compass has been launched by L2S2 partner, C2-Ai, in the UK and the USA. Since launch it has won Health Tech4Covid award at COGX2020, among other awards.
Compass was produced rapidly by L2S2 using its MMDC platform. It encapsulates AI algorithms designed by C2-Ai and developed by L2S2 using >100m health records. It is a registered medical device.
"You're so overly clearly part of our success."Richard Jones, President (US) and Chief Strategy Officer, C2-Ai
Do you have an idea you want to get into the hands of healthcare, fast?
Let us realise your ideas
© 2024 L2S2 Ltd. All Rights Reserved
Privacy Policy | GDPR | ISO 13485:2016 | ISO 27001:2013 | Cyber Essentials | NHS DSP Toolkit | OWASP | HSCN | Mobile Apps